A Report on the International Transglutaminase Autoantibody Workshop for Celiac Disease

No abstract is available for this paper.

• Publication year

  2008

• Venue

  American Journal of Gastroenterology

• Publication date

  2008-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/ajg.2008.8PMID 19098844PMCID PMC2904747
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Levofloxacin

  2012cited by this paper
• Anti-dsDNA antibody assay: high specificity and sensitivity with a filtration radioassay in comparison to low specificity with the standard ELISA.

  2007cited by this paper
• Accepting clocks that tell time poorly: fluid-phase versus standard ELISA autoantibody assays.

  2007cited by this paper
• "Cervia II Working Group Report 2006": guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy.

  2007cited by this paper
• Evolution of Helicobacter pylori Therapy from a Meta‐analytical Perspective

  2007cited by this paper
• Empirical rescue therapy after Helicobacter pylori treatment failure: a 10‐year single‐centre study of 500 patients

  2007cited by this paper
• Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: a multicentre study.

  2007cited by this paper
• Levofloxacin‐Containing Triple Therapy to Eradicate the Persistent H. pylori after a Failed Conventional Triple Therapy

  2007cited by this paper
• Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

  2006cited by this paper
• Third-Line Rescue Therapy with Levofloxacin After Two H. pylori Treatment Failures

  2006cited by this paper
• AGA Institute Medical Position Statement on the Diagnosis and Management of Celiac Disease.

  2006cited by this paper
• Third‐line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures

  2006cited by this paper
• The Evolution of

  2006cited by this paper
• Need for quantitative assessment of transglutaminase autoantibodies for celiac disease in screening-identified children.

  2005cited by this paper
• Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.

  2005cited by this paper
• Helicobacter pylori“Rescue” Therapy After Failure of Two Eradication Treatments

  2005cited by this paper
• H pylori antibiotic resistance: prevalence, importance, and advances in testing

  2004cited by this paper
• Diagnostic accuracy of ten second-generation (human) tissue transglutaminase antibody assays in celiac disease.

  2004cited by this paper
• Review article: 13C‐urea breath test in the diagnosis of Helicobacter pylori infection – a critical review

  2004cited by this paper
• NIH Consensus Development Conference on Celiac Disease.

  2004cited by this paper
• A clinical practice viewpoint: to culture or not to culture Helicobacter pylori?

  2003cited by this paper
• Diabetes Antibody Standardization Program: first assay proficiency evaluation.

  2003cited by this paper
• Current concepts in the management of Helicobacter pylori infection—The Maastricht 2‐2000 Consensus Report

  2002cited by this paper
• Helicobacter pylori ‘rescue’ regimen when proton pump inhibitor‐based triple therapies fail

  2002cited by this paper
• Effectiveness of Helicobacter pylori eradication treatments in a primary care setting in Italy

  2002cited by this paper
• The status of antimicrobial resistance of Helicobacter pylori in eastern Europe.

  2002cited by this paper
• European Helicobacter Pylori Study Group (EHPSG). Current concepts in the management of Helicobacter pylori infection. The Maasticht 2-2000 Consensus Report

  2002cited by this paper
• Radioimmunoassay to detect antitransglutaminase autoantibodies is the most sensitive and specific screening method for celiac disease

  2001cited by this paper
• Efficacy of Helicobacter pylori eradication therapies: a single centre observational study

  2001cited by this paper
• International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice.

  2001cited by this paper
• A triple therapy regimen after failed Helicobacter pylori treatments

  2001cited by this paper
• Efficacy of a multistep strategy for Helicobacter pylori eradication

  2000cited by this paper
• Efficacy of two one‐week rabeprazole/levofloxacin‐based triple therapies for Helicobacter pylori infection

  2000cited by this paper
• Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases.

  2000cited by this paper
• Cure of Helicobacter pylori infection after failed primary treatment: one-center results from 120 patients.

  2000cited by this paper
• Third line treatment for Helicobacter pylori: a prospective, culture‐guided study in peptic ulcer patients

  2000cited by this paper
• Salvage therapies after failure of Helicobacter pylori eradication with ranitidine bismuth citrate‐based therapies

  2000cited by this paper
• Invasive and non‐invasive tests for Helicobacter pylori infection

  2000cited by this paper
• Comparative Evaluation of Serologic Tests for Celiac Disease: A European Initiative Toward Standardization

  2000cited by this paper
• Susceptibilities of Helicobacter pylori strains isolated from children with gastritis to selected antibiotics.

  1999cited by this paper
• Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer.

  1998cited by this paper
• A new approach to cytochrome CYP2D6 antibody detection in autoimmune hepatitis type‐2 (AIH‐2) and chronic hepatitis C virus (HCV) infection: a sensitive and quantitative radioligand assay

  1997cited by this paper
• Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group.

  1997cited by this paper
• Identification of tissue transglutaminase as the autoantigen of celiac disease

  1997cited by this paper
• Current European concepts in the management of Helicobacter pylori infection--the Maastricht Consensus Report. The European Helicobacter Pylori Study Group (EHPSG).

  1997cited by this paper
• Current European concepts in the management of Helicobacter pylori infection the Maastricht Consensus Report

  1997cited by this paper
• IARC Monographs on the Evaluation of Carcinogenic Risks to Humans

  1995cited by this paper
• Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration.

  1984cited by this paper

• Controversies and Opportunities of a Nonbiopsy Diagnosis for Celiac Disease.

  2025cites this paper
• Nationwide survey of coeliac disease serology testing in the UK

  2025cites this paper
• Pathogenesis and genetics of celiac disease; a systematic review

  2025cites this paper
• Coeliac disease: the paradox of diagnosing a food hypersensitivity disorder with autoantibodies

  2024cites this paper
• Novel Information Regarding the Treatment of Helicobacter pylori Infection: A Systematic Review and Meta-analysis of Randomized Clinical Trials.

  2023cites this paper
• EFFICACY AND SAFETY OF GEMIFLOXACIN CONTAINING TREATMENT REGIMEN IN FIRST-LINE TREATMENT OF HELICOBACTER PYLORI.

  2023cites this paper
• American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease.

  2022cites this paper
• Empirical vs. Susceptibility-Guided Treatment of Helicobacter pylori Infection: A Systematic Review and Meta-Analysis

  2022cites this paper
• Standard Triple Therapy as a Remedy for Treatment of Helicobacter pylori Infection: A Systematic Review and Meta-analysis of Randomized Clinical Trials.

  2022cites this paper
• Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report

  2022cites this paper
• V Spanish Consensus Conference on Helicobacter pylori infection treatment.

  2021cites this paper
• Empirical or susceptibility-guided treatment for Helicobacter pylori infection? A comprehensive review

  2020cites this paper
• Safety and Efficacy of Nitazoxanide-Based Regimen for the Eradication of Helicobacter pylori Infection: A Systematic Review and Meta-Analysis

  2020cites this paper
• Hellenic consensus on Helicobacter pylori infection

  2020cites this paper
• Rifabutin for the Treatment of Helicobacter pylori Infection: A Review

  2020cites this paper
• Protocol of the European Registry on the management of Helicobacter pylori infection (Hp‐EuReg)

  2019cites this paper
• Effects of Lactobacillus plantarum and Lactobacillus paracasei on the Peripheral Immune Response in Children with Celiac Disease Autoimmunity: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

  2019cites this paper
• Meta‐analysis of three‐in‐one single capsule bismuth‐containing quadruple therapy for the eradication of Helicobacter pylori

  2019cites this paper
• Refractory Helicobacter Pylori gastritis: The hidden predictors of resistance.

  2019cites this paper
• Prevalence of Celiac Disease in a Long-term Study of a Spanish At-genetic-risk Cohort From the General Population

  2019cites this paper
• Comparison of Levofloxacin-Based, 10-day Sequential Therapy with 14-day Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Clinical Trial

  2018cites this paper
• Cumulative Helicobacter Pylori Eradication Rates by Adopting First- and Second- Line Regimens Proposed by the Maastricht IV Consensus in Obese Patients Undergoing Gastric Bypass Surgery

  2018cites this paper
• Helicobacter Pylori - a Worldwide Perspective 2014

  2018cites this paper
• High antibiotic resistance of Helicobacter pylori and its effect on tailored and empiric eradication of the organism in Lower Silesia, Poland

  2017cites this paper
• A prospective evaluation of levofloxacin‐based triple therapy for refractory Helicobacter pylori infection in Australia

  2017cites this paper
• Illusions regarding Helicobacter pylori clinical trials and treatment guidelines

  2017cites this paper
• Helicobacter Pylori Treatment Results in Slovenia in the Period 2013-2015 as a Part of European Registry on Helicobacter Pylori Management

  2017cites this paper
• Challenges in the Standardization of Autoantibody Testing: a Comprehensive Review

  2017cites this paper
• Treatment of Helicobacter pylori infection: Where are we now?

  2016cites this paper
• Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report

  2016cites this paper
• IV Spanish Consensus Conference on Helicobacter pylori infection treatment.

  2016cites this paper
• Adhesion and Invasion of Gastric Mucosa Epithelial Cells by Helicobacter pylori

  2016cites this paper
• IV Spanish Consensus Conference on Helicobacter pylori infection treatment.

  2016cites this paper
• [[Overview Basic Provisions Consensus of the III Working Italian Group for Diagnosis and Treatment of H.Pylory-Infection].]

  2016cites this paper
• A Review of Helicobacter pylori Infection in Patients with Diabetes Mellitus

  2016cites this paper
• Effectiveness of Second through Sixth Line Salvage Helicobacter pylori Treatment: Bismuth Quadruple Therapy is Almost Always a Reasonable Choice

  2016cites this paper
• Helicobacter pylori vs immune system or antibiotics

  2015cites this paper
• Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015.

  2015cites this paper
• Advances in diagnosis and management of celiac disease.

  2015cites this paper
• Chapter 25. Gastrointestinal Diseases

  2015cites this paper
• Accuracy of various diagnostic tests and antimicrobial sensitivity pattern of Helicobacter pylori infection in a tertiary care centre in Nepal

  2015cites this paper
• Linee guida per la diagnosi di laboratorio e istologica della malattia celiaca. Revisione 2015

  2015cites this paper
• Update on the Diagnosis and Management of Helicobacter pylori Infection in Adults.

  2015cites this paper
• Probiotics in Helicobacter pylori eradication therapy: a systematic review and meta-analysis.

  2015cites this paper
• Efficacy of Levofloxacin Based Triple and High-Dose PPI-Amoxicillin Dual Eradication Therapy for Helicobacter pylori after Failures of First- and Second-Line Therapies

  2014cites this paper
• The Trend of First-Line and Second-Line Eradication Rates for Helicobacter pylori Infection in a Single Institute in Seoul

  2014influential citation
• Third-Line Rescue Therapy with Bismuth-Containing Quadruple Regimen After Failure of Two Treatments (with Clarithromycin and Levofloxacin) for H. pylori Infection

  2014cites this paper
• An Efficacious and Cost-Effective Pharmacologic Treatment for Helicobacter pylori

  2014cites this paper
• Population based Helicobacter pylori screening and eradication: advances versus side effects.

  2014cites this paper
• Helicobacter pylori: Evidence-Based Review with a Focus on Immigrant Populations

  2014cites this paper
• High risk of failing eradication of Helicobacter pylori in patients with diabetes: a meta-analysis.

  2014cites this paper
• Optimal treatment strategy for Helicobacter pylori: era of antibiotic resistance.

  2014cites this paper
• Chapter 20. Peptic Ulcer Disease

  2014cites this paper
• Long-standing type 1 diabetes: patients with adult-onset develop celiac-specific immunoreactivity more frequently than patients with childhood-onset diabetes, in a disease duration-dependent manner

  2014cites this paper
• Current and future insights in H. pylori eradication regimens: the need of tailoring therapy.

  2014cites this paper
• Levofloxacin and proton pump inhibitor‐based triple therapy versus standard triple first‐line therapy for Helicobacter pylori eradication

  2014cites this paper
• Fluoroquinolone-based protocols for eradication of Helicobacter pylori.

  2014cites this paper
• Study subjects were those diagnosed as having H. pylori infection by the urea breath test, serum H. pylori immunoglobulin G, H. pylori antigen in stool, rapid urease test, or histopathological examination and received first-line PPI/AC therapy (lansoprazole

  2014cites this paper
• Randomised Clinical Trial Comparing the Efficacy of A Gluten-Free Diet Versus A Regular Diet in A Series of Relapsing-Remitting Multiple Sclerosis Patients

  2014cites this paper
• Clinical Management of Helicobacter pylori: The Latin American Perspective

  2014cites this paper
• III Conferencia Espade Consenso sobre la infección por Helicobacter pylori III Spanish Consensus Conference on Helicobacter pylori infection

  2013cites this paper
• Nuevas estrategias terapéuticas en la infección por Helicobacter pylori

  2013cites this paper
• Infeção por Helicobacter Pylori Da Epidemiologia ao Tratamento

  2013cites this paper
• [III Spanish Consensus Conference on Helicobacter pylori infection].

  2013cites this paper
• Optimum duration of regimens for Helicobacter pylori eradication.

  2013cites this paper
• 3rd Brazilian Consensus on Helicobacter pylori.

  2013cites this paper
• Treatment of gastric MALT lymphoma with a focus on Helicobacter pylori eradication

  2013cites this paper
• Multi-center randomized controlled study to establish the standard third-line regimen for Helicobacter pylori eradication in Japan

  2013cites this paper
• Comparison of 10 day bismuth quadruple therapy with high-dose metronidazole or levofloxacin for second-line Helicobacter pylori therapy: a randomized controlled trial.

  2013cites this paper
• Second-line Therapy With Levofloxacin After Failure of Treatment to Eradicate Helicobacter pylori Infection: Time Trends in a Spanish Multicenter Study of 1000 Patients

  2013cites this paper
• Therapy for H. pylori : Current concepts

  2013cites this paper
• Modified sequential therapy regimens for Helicobacter pylori eradication: a systematic review.

  2013cites this paper
• Treatment for H. pylori Infection: New Challenges With Antimicrobial Resistance

  2013cites this paper
• Current options for the treatment of Helicobacter pylori

  2013cites this paper
• Helicobacter pylori infection and diabetes mellitus: the 2013 state of art.

  2013cites this paper
• Standard triple and sequential therapies for Helicobacter pylori eradication: an update.

  2013cites this paper
• Ten-Year Trend of the Cumulative Helicobacter pylori Eradication Rate for the ‘Japanese Eradication Strategy'

  2013cites this paper
• Methods, quality control and specimen management in an international multicentre investigation of type 1 diabetes: TEDDY

  2013cites this paper
• A review of rescue regimens after clarithromycin-containing triple therapy failure (for Helicobacter pylori eradication)

  2013cites this paper
• The Next Big Idea

  2013cites this paper
• ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease

  2013cites this paper
• Chemiluminescence and ELISA-based serum assays for diagnosing and monitoring celiac disease in children: a comparative study.

  2013cites this paper
• Cumulative Helicobacter pylori Eradication Therapy in Obese Patients Undergoing Gastric Bypass Surgery

  2013cites this paper
• Nonbismuth Quadruple “Concomitant” Therapy Versus Standard Triple Therapy, Both of the Duration of 10 Days, for First-Line H. Pylori Eradication: A Randomized Trial

  2013cites this paper
• Clinical Evaluation of a Ten‐Day Regimen with Esomeprazole, Metronidazole, Amoxicillin, and Clarithromycin for the Eradication of Helicobacter pylori in a High Clarithromycin Resistance Area

  2013cites this paper
• Principales indicaciones para el tratamiento de erradicación contra Helicobacter pylori y evaluación de tres esquemas de tratamiento

  2013cites this paper
• Which Treatment in Helicobacter pylori Infection

  2013cites this paper
• Efficacy of a therapeutic strategy for eradication of Helicobacter pylori infection.

  2012cites this paper
• Helicobacter pylori Infection: Sequential Therapy Followed by Levofloxacin‐Containing Triple Therapy provides a Good Cumulative Eradication Rate

  2012cites this paper
• Helicobacter   pylori Eradication Therapies in the Era of Increasing Antibiotic Resistance: A Paradigm Shift to Improved Efficacy

  2012cites this paper
• IgA Anti-transglutaminase Autoantibodies at Type 1 Diabetes Onset Are Less Frequent in Adult Patients and Are Associated With a General Celiac-Specific Lower Immune Response in Comparison With Nondiabetic Celiac Patients at Diagnosis

  2012cites this paper
• Salvage Options for Eradication of Helicobacter pylori During Tetracycline Backorder

  2012cites this paper
• Trends in the eradication rates of Helicobacter pylori infection for eleven years.

  2012cites this paper
• Different Antibiotic No Culture Eradicating (DANCE) strategy: an easy way to manage H. pylori eradication.

  2012cites this paper
• [Helicobacter pylori eradication frequency with the conventional triple therapy in adult patients at the Centro Médico Issemym].

  2012cites this paper
• Review article: rifabutin in the treatment of refractory Helicobacter pylori infection

  2012cites this paper
• Letter: third‐line rescue therapy with levofloxacin after failure of two treatments to eradicate Helicobacter pylori infection

  2012cites this paper
• Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report

  2012cites this paper
• Furazolidone-based Therapies for Helicobacter pylori Infection: A Pooled-data Analysis

  2012cites this paper
• Rescue Therapy for Helicobacter pylori Infection 2012

  2012cites this paper